DC Advisory advises CorrIT Ltd. on its sale to Aris Global

Background

• Based in Ireland, CorrIT t/a SPORIFY, is a trusted SPOR (Substances, Products, Organizations, and Referentials) data harmonization technology solution for five of the world’s largest pharmaceutical companies and several European regulators
• ArisGlobal is a leading provider of life sciences software designed to automate core drug development functions with its end-to-end technology platform, LifeSphere

Process

• DC Advisory acted as exclusive financial advisor to the shareholders of CorrIT on its sale of CorrIT to ArisGlobal
• DC advisory assisted in managing the due diligence process
• DC Advisory negotiated the key commercial terms of the transaction with the buy-side advisors

Outcome

• CorrIT’s acquisition by ArisGlobal builds onto their existing broad set of regulatory capabilities
• This transaction further showcases DC Advisory’s deep expertise in the Technology & Software space

“From start to finish, the team at IBI expertly guided us through each step of the sales process. They helped us deliver a deal with a large global player that makes us genuinely excited about the future of our technology within the wider ArisGlobal Group.”